Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 3Pain 3Colorectal Neoplasms 2Supratentorial Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Oropharyngeal Neoplasms 1Neoplasms 1Meningioma 1Lung Neoplasms 1Liver Neoplasms 1Liver Diseases 1Colonic Neoplasms 1Cancer Pain 1Breast Neoplasms 1Benign Gynecologic Neoplasm 1Agnosia 1Acute Pain 1Abdominal Neoplasms 1

Interventions

Fluorouracil 34Leucovorin 31Oxaliplatin 25Irinotecan 19Capecitabine 13Folfox protocol 12Cetuximab 12Chemotherapy, Adjuvant 11Bevacizumab 9Neoadjuvant Therapy 8Drug Therapy 8XELOX 7Laparoscopy 7Endoscopic Mucosal Resection 5Colonoscopy 5Surgical Procedures, Operative 4Gemcitabine 4Tegafur 3Radiotherapy 3Propofol 3Preoperative Exercise 3Panitumumab 3Fentanyl 3Curcumin 3Colectomy 3Aspirin 3raltitrexed 2Surveys and Questionnaires 2Sodium Chloride 2Simvastatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colonic Neoplasms × Ropivacaine × Clear all
NCT02326727 2014-12-29

Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery

Hillel Yaffe Medical Center

Phase NA Unknown
30 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡